byiShook Opinion
Jul 31, 2024 - 10:50
GSK stock fell early Wednesday on light sales of two key vaccines, Shingrix and Arexvy, though the company otherwise beat expectations. The post GSK Beats Second-Quarter Views, Raises Outlook; But Shares Fall On Shingrix Miss appeared first on Investor's Business Daily.
GSK stock fell early Wednesday on light sales of two key vaccines, Shingrix and Arexvy, though the company otherwise beat expectations.
The post GSK Beats Second-Quarter Views, Raises Outlook; But Shares Fall On Shingrix Miss appeared first on Investor's Business Daily.